The UK has authorized the use of the Pfizer-BioNTech vaccine in children aged 12-15, stating it is safe and effective in this age group and the benefits outweigh the risks.
The MHRA announced it had carried out a “rigorous review” of the vaccine in these adolescents.
The UK’s vaccines committee will now decide whether children should get the jab.
What's happening in Tunisia?
Subscribe to our Youtube channel for updates.
